Overview

Name: Cerebrolysin
Therapy Type: Other
Target Type: Other (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Phase 2)
Status in Select Countries: Approved outside the U.S. for cognitive impairment.
Company: Ebewe Pharmaceutical
Approved for:

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

No Available References

Further Reading

No Available Further Reading